<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Northwestern_09_08 skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Northwestern/09 08</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>Notebook</TITLE></P><DIV class="container-fluid" id="cntr"><ARTICLE><H1>Thursday, September 8<SUP>th</SUP></H1><H2>Western Blot Results:</H2><H2>Tasks:</H2><DIV class="row"><DIV class="col-sm-2"><P>Jordan</P></DIV><DIV class="col-sm-10"><UL><LI>Helped with Western blot in the morning</LI><LI>Looked into alternative periplasm fraction options</LI><LI>Transformed Golden Gates and Gibsons</LI><UL><LI>1 uL of Patrick’s transformation control on Amp</LI><LI>1 uL of Gibson YcdO product on Cam</LI><LI>2 uL “   “   “</LI><LI>3 uL “    “   “</LI><LI>4 uL “   “   “</LI><LI>3 ul of positive Golden Gate control from Patrick on Amp</LI><LI>3 ul GG control w/ no ligase on Amp</LI><LI>3 uL GG control w/ no insert on Amp</LI><LI>3 uL gRNA-guide GG on Tet</LI><LI>3 uL GFP-mcherry Golden Gate on Cam</LI></UL><UL><LI>Used 950 uL of SOC and plated 2 plates of each</LI><LI>Incubated for 1 hr. 15 minutes </LI></UL></UL></DIV></DIV><DIV class="row"><DIV class="col-sm-2"><P>Michelle</P></DIV><DIV class="col-sm-10"><UL><LI>Ran gel on Cas9-SS Gibsons (2)</LI><UL><LI>Completely empty</LI></UL><LI>Made 40 fmol/uL dilutions of gRNA template, mCherry1, and Tet lnrz for GFP for GG Golden Gate assembly</LI><LI>Ran Golden Gate reactions</LI><UL><LI>mCherry:</LI><UL><LI>1 uL of 40 fmol/uL mCherry1 PCR product</LI><LI>1 uL of 40 fmol/uL Tet lrnz for GFP PCR product</LI><LI>1 uL of 40 fmol/uL TorA</LI><LI>2 uL of 10X T4 ligase buffer</LI><LI>2.24 uL of 110uL BSA + 10uL T4 ligase buffer</LI><LI>0.5 uL of 400,000U/mL T4 ligase from NEB</LI><LI>0.5 uL of BsaI</LI><LI>Water to 21.76 uL</LI></UL><LI>gRNA:</LI><UL><LI>1 uL of 40 fmol/uL gRNA template</LI><LI>1 uL of annealed cutting guide insert from primers (straight from tube: ~ 6 uM)</LI><LI>2 uL of 10X T4 ligase buffer</LI><LI>2.24 uL of 110uL BSA + 10uL T4 ligase buffer</LI><LI>0.5 uL of 400,000U/mL T4 ligase from NEB</LI><LI>0.5 uL of BsaI</LI><LI>Water to 21.76 uL</LI></UL><LI>Positive control:</LI><UL><LI>1 uL of Patrick’s positive control “32, 50ng”</LI><LI>1 uL of Patrick’s positive control</LI><LI>2 uL of 10X T4 ligase buffer</LI><LI>2.24 uL of 110uL BSA + 10uL T4 ligase buffer</LI><LI>0.5 uL of 400,000U/mL T4 ligase from NEB</LI><LI>0.5 uL of BsaI</LI><LI>Water to 21.76 uL</LI></UL><LI>Negative control (no ligase):</LI><UL><LI>1 uL of Patrick’s positive control “32, 50ng”</LI><LI>1 uL of Patrick’s positive control</LI><LI>2 uL of 10X T4 ligase buffer</LI><LI>2.24 uL of 110uL BSA + 10uL T4 ligase buffer</LI><LI>0.5 uL of BsaI</LI><LI>Water to 21.76 uL</LI></UL><LI>Negative control (no insert):</LI><UL><LI>1 uL of Patrick’s positive control “32, 50ng”</LI><LI>2 uL of 10X T4 ligase buffer</LI><LI>2.24 uL of 110uL BSA + 10uL T4 ligase buffer</LI><LI>0.5 uL of 400,000U/mL T4 ligase from NEB</LI><LI>0.5 uL of BsaI</LI><LI>Water to 21.76 uL</LI></UL><LI>Conditions:</LI><UL><LI>30 cycles, 37°C (2:00) 16°C (2:00) 50°C (5:00) 80°C (5:00)</LI></UL></UL><LI>In the future add 2 uL of 10X BSA in every reaction tube</LI></UL></DIV></DIV><DIV class="row"><DIV class="col-sm-2"><P>Paul</P></DIV><DIV class="col-sm-10"><UL><LI>Finished Western Blot procedure with Ben</LI><LI>TetR plasmid expressed less Cas9 than Top10</LI><UL><LI>Fraction procedure may need revision:</LI><UL><LI>Slight Cas9 residue in periplasm fraction</LI></UL><LI>Lanes:</LI><UL><LI>1: ladder</LI><LI>2: Whole cell ClyA-GFP</LI><LI>3: Whole cell Neg control</LI><LI>4: Whole cell Cas9 in pSB1C3 (Tet promoter)</LI><LI>5: periplasm ClyA-GFP</LI><LI>6: periplasm Neg control</LI><LI>7: periplasm Cas9 in pSB1C3 (Tet promoter)</LI><LI>8: ladder</LI></UL></UL><LI>Phosphorylate and anneal gRNA primers:</LI><UL><LI>1 uL PNK</LI><LI>0.61 uL of 100 uM primer 1</LI><LI>0.61 uL of 100 uM primer 2</LI><LI>2 uL T4 ligase buffer</LI><LI>Water to 20 uL</LI><LI>@ 37°C for 30 min @ 95°C for 5 min</LI><LI>Cool to 28 C at ~1°C/min</LI></UL></UL></DIV></DIV><DIV class="row"><DIV class="col-sm-2"><P>Sam</P></DIV><DIV class="col-sm-10"><UL><LI>Reached out to museums</LI><LI>Put finishing touches on pamphlet</LI><LI>Began writing human practices section for website</LI><LI>Began writing collaboration section for website</LI><LI>Emailed Australia </LI></UL></DIV></DIV><DIV class="row"><DIV class="col-sm-2"><P>Sara</P></DIV><DIV class="col-sm-10"><UL><LI>Read through the Australians’ protocols and made a list of questions and things that we would need to do them</LI><LI>Did a little lab notebook work</LI><LI>Plated the gibson Ycdo and Cas9 gibson products</LI><UL><LI>500 uL of the 1000 uL total solutions onto 2 plates each </LI></UL></UL></DIV></DIV><DIV class="row"><DIV class="col-sm-2"><P>Tyler</P></DIV><DIV class="col-sm-10"><UL><LI>Mathematical modeling, looked into and researched other antibiotic resistant targets</LI><LI>Gibson Reaction (Ycdo)</LI><UL><LI>2.78 n.f. H<SUB>2</SUB>0</LI><LI>0.22 µL Ycdo Insert</LI><LI>2 µL (36 ng) SS Lnrz Cas9</LI><LI>5 µL Gibson Mix </LI></UL></UL></DIV></DIV></ARTICLE><FOOTER id="nav"><DIV class="row"><DIV class="col-sm-4"><A href="https://2016.igem.org/Team:Northwestern/09_07"> yesterday</A></DIV><DIV class="col-sm-4"><A href="https://2016.igem.org/Team:Northwestern/Notebook">back to calendar </A></DIV><DIV class="col-sm-4"><A href="https://2016.igem.org/Team:Northwestern/09_09">tomorrow </A></DIV></DIV></FOOTER></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>